Prescient Therapeutics Limited Share Price
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:11 30/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0530 AUD | -3.64% |
|
-5.36% | -36.90% |
| 23/10 | Prescient Therapeutics Limited Announces Management Changes, Effective October 23, 2026 | CI |
| 21/10 | Prescient Therapeutics Limited - Special Call |
| Market Cap | 6.06Cr 4.27Cr 3.82Cr 3.51Cr 3.18Cr 5.95Cr 404.97Cr 42Cr 17Cr 213.03Cr 16Cr 16Cr 671.81Cr | P/E 2025 |
-4.84x | P/E 2026 | -8.94x |
|---|---|---|---|---|---|
| Enterprise Value | 5.18Cr 3.64Cr 3.26Cr 3Cr 2.72Cr 5.08Cr 346.02Cr 36Cr 14Cr 182.02Cr 14Cr 13Cr 574.01Cr | EV / Sales 2025 |
6.54x | EV / Sales 2026 | 16x |
| Free-Float |
94.89% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PTX | Delayed | |
Deutsche Boerse AG
| UDD | Delayed |
Last Transcript: Prescient Therapeutics Limited
| 1 day | -3.64% | ||
| 1 week | -5.36% | ||
| Current month | -20.90% | ||
| 1 month | -26.39% | ||
| 3 months | -34.57% | ||
| 6 months | +3.92% | ||
| Current year | -36.90% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 20/01/2025 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 30/03/2025 |
Allen Ebens
BRD | Director/Board Member | - | 01/06/2020 |
Ellen Feigal
BRD | Director/Board Member | 71 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Buy | Director | 2,00,000 | 0.0175% | ||
| 30/09/26 | Buy | Chairman | 1,53,846 | 0.0134% | ||
| 30/09/26 | Buy | Director | 76,923 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.64% | -5.36% | +8.16% | -13.11% | 4.43Cr | |
| -0.62% | +0.50% | +33.92% | +60.07% | 6.44TCr | |
| +0.35% | +3.04% | +12.64% | +83.62% | 5.62TCr | |
| +0.53% | +2.55% | +13.90% | +104.77% | 5.42TCr | |
| -2.81% | -3.95% | +22.72% | +48.57% | 4.53TCr | |
| -0.33% | -3.12% | +17.62% | +117.27% | 4.22TCr | |
| +0.55% | +1.93% | +229.73% | +928.00% | 4.08TCr | |
| +3.27% | +47.40% | +110.44% | +94.92% | 3.38TCr | |
| +1.22% | -1.39% | +13.92% | +46.95% | 3.22TCr | |
| -1.29% | -1.72% | +21.00% | -6.85% | 2.36TCr | |
| Average | -0.29% | +4.07% | +48.41% | +146.42% | 3.93TCr | |
| Weighted average by Cap. | +0.01% | +3.64% | +49.57% | +162.45% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 43.56L 30.65L 27.45L 25.25L 22.88L 42.76L 29Cr 3.01Cr 1.21Cr 15Cr 1.15Cr 1.13Cr 48Cr | 34.51L 24.28L 21.74L 20L 18.12L 33.88L 23Cr 2.39Cr 95.75L 12Cr 91.12L 89.18L 38Cr |
| Net income | -73.23L -51.52L -46.14L -42.44L -38.45L -71.88L -49Cr -5.06Cr -2.03Cr -26Cr -1.93Cr -1.89Cr -81Cr | -70.03L -49.27L -44.12L -40.59L -36.77L -68.74L -47Cr -4.84Cr -1.94Cr -25Cr -1.85Cr -1.81Cr -78Cr |
| Net Debt | -69.27L -48.73L -43.64L -40.15L -36.38L -68L -46Cr -4.79Cr -1.92Cr -24Cr -1.83Cr -1.79Cr -77Cr | -88.25L -62.09L -55.61L -51.15L -46.34L -86.63L -59Cr -6.1Cr -2.45Cr -31Cr -2.33Cr -2.28Cr -98Cr |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | A$0.0530 | -3.64% | 1,91,792 |
| 29/26/29 | A$0.0550 | +5.77% | 17,580 |
| 28/26/28 | A$0.0520 | -3.70% | 4,57,731 |
| 27/26/27 | A$0.0540 | +5.88% | 2,71,970 |
| 26/26/26 | A$0.0510 | -5.56% | 15,89,874 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
